Columbia University Medical Center, New York, NY.
Penn State Hershey Medical Center, Hershey, PA.
Transplantation. 2021 Aug 1;105(8):1677-1684. doi: 10.1097/TP.0000000000003581.
Intraoperative fluid management may affect the outcome after kidney transplantation. However, the amount and type of fluid administered, and monitoring techniques vary greatly between institutions and there are limited prospective randomized trials and meta-analyses to guide fluid management in kidney transplant recipients.
Members of the American Society of Anesthesiologists (ASA) committee on transplantation reviewed the current literature on the amount and type of fluids (albumin, starches, 0.9% saline, and balanced crystalloid solutions) administered and the different monitors used to assess fluid status, resulting in this consensus statement with recommendations based on the best available evidence.
Review of the current literature suggests that starch solutions are associated with increased risk of renal injury in randomized trials and should be avoided in kidney donors and recipients. There is no evidence supporting the routine use of albumin solutions in kidney transplants. Balanced crystalloid solutions such as Lactated Ringer are associated with less acidosis and may lead to less hyperkalemia than 0.9% saline solutions. Central venous pressure is only weakly supported as a tool to assess fluid status.
These recommendations may be useful to anesthesiologists making fluid management decisions during kidney transplantation and facilitate future research on this topic.
术中液体管理可能会影响肾移植后的结果。然而,各机构之间给予的液体量和类型以及监测技术差异很大,并且有限的前瞻性随机试验和荟萃分析可以指导肾移植受者的液体管理。
美国麻醉师学会(ASA)移植委员会的成员回顾了目前关于给予的液体量和类型(白蛋白、淀粉、0.9%生理盐水和平衡晶体溶液)以及用于评估液体状态的不同监测器的文献,导致了这一共识声明,并根据最佳现有证据提出了建议。
对当前文献的回顾表明,淀粉溶液与随机试验中肾脏损伤的风险增加有关,因此应避免在肾脏供体和受体中使用。没有证据支持在肾移植中常规使用白蛋白溶液。平衡晶体溶液(如乳酸林格氏液)与酸中毒的发生较少有关,并且可能导致低钾血症的发生率低于 0.9%生理盐水溶液。中心静脉压仅被弱支持作为评估液体状态的工具。
这些建议可能对麻醉师在肾移植期间做出液体管理决策有用,并促进该主题的未来研究。